Progress versus precision: challenges in clinical trial design for left ventricular assist devices

Area of Science:

• Cardiovascular Medicine
• Medical Device Technology
• Clinical Trial Design

Background:

• Left ventricular assist devices (LVADs) are advancing, aiming to reduce adverse events.
• Current LVADs offer limited survival improvements, posing challenges for clinical trials.
• The growing number of LVADs in development necessitates efficient evaluation methods.

Purpose of the Study:

• To propose novel clinical trial designs for left ventricular assist devices.
• To address challenges in premarketing trials for LVADs, particularly in destination therapy.
• To facilitate innovation and efficient evaluation of new LVAD technologies.

Main Methods:

• Advocating for small, randomized trials to maintain randomization benefits and shorten enrollment.
• Proposing a shift towards robust postmarketing studies for ongoing device evaluation.
• Leveraging existing infrastructure like the Interagency Registry of Mechanically Assisted Circulatory Support.

Main Results:

• Small randomized trials can preserve randomization advantages with shorter enrollment periods.
• Postmarketing studies offer a robust framework for evaluating LVADs.
• Proposed methods aim to improve the efficiency of LVAD clinical evaluation.

Conclusions:

• Novel trial designs, including small randomized trials, are essential for LVAD development.
• A strategic shift to postmarketing surveillance is recommended for comprehensive device assessment.
• These approaches will support continued innovation in mechanical circulatory support.